InMicro® Prepared: Burkholderia Cepacia Selective Agar is used to selectively isolate and differentiate Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
$217.00
Selectively isolate and differentiate Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis with InMicro® Prepared: Burkholderia Cepacia Selective Agar plates. Selective agents crystal violet, polymixin B, gentamicin, and vancomycin inhibit organisms commonly found in respiratory secretions other than B. cepacia complex. Sucrose and lactose are carbohydrates for enrichment and differentiation with phenol red as a pH indicator. B. cepacia appear as yellow colonies on the medium.
Since the mid 1980’s, B.cepacia complex has been recognized as an important pathogen affecting patients with cystic fibrosis. Colonization and pulmonary infection with this organism have been associated with a rapid decline in pulmonary function and poor patient prognosis.
Manufactured at a cGMP-compliant facility under the ISO 13485 standard, ensuring high-quality manufacturing standards, consistency, and reliability for both research and industrial settings.
Agar
Monoplate
Product Quantity | Pack of 10 |
---|